Chan KK - Search Results

1

Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.

Wong WW, Hicks LK, Tu HA, Pritchard KI, Krahn MD, Feld JJ, Chan KK. Wong WW, et al. Among authors: chan kk. Breast Cancer Res Treat. 2015 Jun;151(3):639-52. doi: 10.1007/s10549-015-3382-7. Epub 2015 May 12. Breast Cancer Res Treat. 2015. PMID: 25962692

2

Cost-utility analysis of primary prophylaxis versus secondary prophylaxis with granulocyte colony-stimulating factor in elderly patients with diffuse aggressive lymphoma receiving curative-intent chemotherapy.

Chan KK, Siu E, Krahn MD, Imrie K, Alibhai SM. Chan KK, et al. J Clin Oncol. 2012 Apr 1;30(10):1064-71. doi: 10.1200/JCO.2011.36.8647. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393098

3

Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.

Zurawska U, Hicks LK, Woo G, Bell CM, Krahn M, Chan KK, Feld JJ. Zurawska U, et al. Among authors: chan kk. J Clin Oncol. 2012 Sep 10;30(26):3167-73. doi: 10.1200/JCO.2011.40.7510. Epub 2012 Jun 18. J Clin Oncol. 2012. PMID: 22711851

4

Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study.

de Oliveira C, Bremner KE, Pataky R, Gunraj N, Chan K, Peacock S, Krahn MD. de Oliveira C, et al. CMAJ Open. 2013 Jan 16;1(1):E1-8. doi: 10.9778/cmajo.20120013. eCollection 2013 Jan. CMAJ Open. 2013. PMID: 25077097 Free PMC article.

5

Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study.

de Oliveira C, Bremner KE, Pataky R, Gunraj N, Haq M, Chan K, Cheung WY, Hoch JS, Peacock S, Krahn MD. de Oliveira C, et al. CMAJ Open. 2013 Dec 9;1(4):E151-8. doi: 10.9778/cmajo.20130041. eCollection 2013 Oct. CMAJ Open. 2013. PMID: 25077117 Free PMC article.

6

Cost-effectiveness analysis of staging strategies in patients with regionally metastatic melanoma.

Look Hong NJ, Petrella T, Chan K. Look Hong NJ, et al. J Surg Oncol. 2015 Mar 15;111(4):423-30. doi: 10.1002/jso.23833. Epub 2014 Nov 24. J Surg Oncol. 2015. PMID: 25422047

7

Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D.

Lee EK, Wong WW, Trudeau ME, Chan KK. Lee EK, et al. Among authors: chan kk. Breast Cancer Res Treat. 2015 Feb;150(1):169-80. doi: 10.1007/s10549-015-3309-3. Epub 2015 Feb 19. Breast Cancer Res Treat. 2015. PMID: 25694355

8

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis.

Mozessohn L, Chan KK, Feld JJ, Hicks LK. Mozessohn L, et al. Among authors: chan kk. J Viral Hepat. 2015 Oct;22(10):842-9. doi: 10.1111/jvh.12402. Epub 2015 Mar 13. J Viral Hepat. 2015. PMID: 25765930 Review.

9

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening.

Visram A, Chan KK, McGee P, Boro J, Hicks LK, Feld JJ. Visram A, et al. Among authors: chan kk. PLoS One. 2015 Apr 15;10(4):e0120749. doi: 10.1371/journal.pone.0120749. eCollection 2015. PLoS One. 2015. PMID: 25875198 Free PMC article.

10

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis.

Prica A, Chan K, Cheung M. Prica A, et al. Cancer. 2015 Aug 1;121(15):2637-45. doi: 10.1002/cncr.29372. Epub 2015 Apr 15. Cancer. 2015. PMID: 25877511 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,183 results

Search Page

Filters